29 mai, 2013by Mario29 May 2013Alethia Biothérapeutiques annonce des ententes de licence et de recherche pour son inhibiteur de la TEM avec IBC Generium Alethia 130529 FR Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.